Peter Bisgaard

Chairman at

Engrail Therapeutics, Inc.

52 year

62 connections

Health Technology

Finance

Commercial Services

Profile

Peter Tuxen Bisgaard is currently the Chairman at Oncxerna Therapeutics, Inc. and Engrail Therapeutics, Inc. He is also the Managing Director at Novo Ventures 1 A, the Director at The Outpost Ltd., and the Managing Director at Nan Fung Life Sciences.
Additionally, he is the Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC since 2017.
In his former positions, Mr. Bisgaard served as the Chairman at HTG Molecular Diagnostics, Inc. from 2015 to 2017.
He was also the Chairman at Neurokey A and Otonomy, Inc. from 2013 to 2015.
Furthermore, he held the role of Independent Director at Ra Pharmaceuticals, Inc. from 2015 to 2019.
He has also served as an Independent Non-Executive Director at Eargo, Inc. from 2017 to 2022.
Additionally, he held various director positions at Light Sciences Oncology, Inc., Asante Solutions, Inc., Thesan Pharmaceuticals, Inc., Azanta Danmark A, Lundbeck Seattle BioPharmaceuticals, Inc., Nevro Corp., Hemofocus ApS, Altheos, Inc., Ceterix Orthopaedics, Inc., Bolt Biotherapeutics, Inc., Entasis Therapeutics, Inc., Chromaderm, Inc., Outpost Medicine, Inc., and Inozyme Pharma, Inc. He was also a Principal at McKinsey & Co., Inc. and a Senior Partner at Novo Holdings AS (Denmark) from 2009 to 2017.
Mr. Bisgaard obtained his graduate degree from the Technical University of Denmark in 1998.

Peter Bisgaard active positions

Companies	Position	Start
The Outpost Ltd. The Outpost Ltd. Marine ShippingTransportation The Outpost Ltd. is an American multifaceted company specializing in helping technology startups and scaleups access, win, and scale federal government contracts, particularly in the defense, energy, and data sectors. The company is based in Hico. The company provides government go-to-market services such as strategy design, proposal writing, compliance, and customer validation, allowing clients to focus on product development while navigating procurement processes. The Outpost leverages expertise from former federal innovation leaders and proprietary AI tools to optimize contract strategies across all growth stages. In addition to contract facilitation, The Outpost operates Outpost Ventures, an investment arm that backs dual-use companies developing technologies aligned with national security and commercial scalability, investing in areas like energy infrastructure, digital infrastructure, defense systems, and applied AI. The company also partners with government teams to design and execute federal innovation programs, offering services such as innovation project management, technology scouting, needs assessments, training, and accelerated technology deployment.	Director/Board Member	-
Pivotal Bioventure Partners Investment Advisor LLC Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions.	Private Equity Investor	01/09/2017
Engrail Therapeutics, Inc. Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for treating neuron diseases	Chairman	-
Oncxerna Therapeutics, Inc. Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs	Chairman	-
Nan Fung Life Sciences Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences invests in companies located across the globe. The firm focuses on life sciences sectors such as health technology, biotechnology, pharmaceuticals, electrical instruments and medical services. It provides financing for seed, early and growth stage capital requirements.	Private Equity Investor	-

All active positions of Peter Bisgaard

Former positions of Peter Bisgaard

Companies	Position	End
EARGO, INC.	Director/Board Member	03/08/2022
RA PHARMACEUTICALS, INC.	Director/Board Member	11/06/2019
HTG MOLECULAR DIAGNOSTICS, INC.	Chairman	07/03/2017
Novo Holdings A/S (Denmark) Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager	Corporate Officer/Principal	01/01/2017
░░░░░░░	░░░░░░░░	░░░░░░░░░░

See the detail of Peter Bisgaard's experience

Training of Peter Bisgaard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Bisgaard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	28
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions	Commercial Services
Light Sciences Oncology, Inc. Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Provides light infusion therapy systems	Health Technology
Asante Solutions, Inc. Asante Solutions, Inc. Medical SpecialtiesHealth Technology Develops insulin delivery devices	Health Technology
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease	Health Technology
Thesan Pharmaceuticals, Inc. Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces novel therapeutics for skin disorders	Health Technology
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Novo Holdings A/S (Denmark) Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager	Finance
Technical University of Denmark Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Azanta Danmark A/S Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases	Health Technology
Lundbeck Seattle BioPharmaceuticals, Inc. Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases	Health Technology
Nevro Corp. Nevro Corp. Medical SpecialtiesHealth Technology Operates as a medical device company	Health Technology
Novo Ventures 1 A/S Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements.	Finance
Neurokey A/S Neurokey A/S Pharmaceuticals: MajorHealth Technology Develops drugs for the critical care field	Health Technology
Hemofocus ApS Hemofocus ApS Medical SpecialtiesHealth Technology Provides anticoagulant products	Health Technology
Otonomy, Inc. Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases	Health Technology
Altheos, Inc. Altheos, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Ceterix Orthopaedics, Inc. Ceterix Orthopaedics, Inc. Medical SpecialtiesHealth Technology Develops novel surgical tools for arthroscopic procedures	Health Technology
Bolt Biotherapeutics, Inc. Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company	Health Technology
Eargo, Inc. Eargo, Inc. Medical SpecialtiesHealth Technology Designs and manufactures hearing aids	Health Technology
Entasis Therapeutics, Inc. Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases	Health Technology
Chromaderm, Inc. Chromaderm, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotech company which develops topical PKC-beta inhibitor	Health Technology
Outpost Medicine, Inc. Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities	Health Technology
The Outpost Ltd. The Outpost Ltd. Marine ShippingTransportation The Outpost Ltd. is an American multifaceted company specializing in helping technology startups and scaleups access, win, and scale federal government contracts, particularly in the defense, energy, and data sectors. The company is based in Hico. The company provides government go-to-market services such as strategy design, proposal writing, compliance, and customer validation, allowing clients to focus on product development while navigating procurement processes. The Outpost leverages expertise from former federal innovation leaders and proprietary AI tools to optimize contract strategies across all growth stages. In addition to contract facilitation, The Outpost operates Outpost Ventures, an investment arm that backs dual-use companies developing technologies aligned with national security and commercial scalability, investing in areas like energy infrastructure, digital infrastructure, defense systems, and applied AI. The company also partners with government teams to design and execute federal innovation programs, offering services such as innovation project management, technology scouting, needs assessments, training, and accelerated technology deployment.	Transportation
Inozyme Pharma, Inc. Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines	Health Technology
Pivotal Bioventure Partners Investment Advisor LLC Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions.	Finance
Nan Fung Life Sciences Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences invests in companies located across the globe. The firm focuses on life sciences sectors such as health technology, biotechnology, pharmaceuticals, electrical instruments and medical services. It provides financing for seed, early and growth stage capital requirements.	Finance
Oncxerna Therapeutics, Inc. Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs	Health Technology
Engrail Therapeutics, Inc. Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for treating neuron diseases	Health Technology